Dominican Republic vs Lithuania: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Dominican Republic
87.0%
in 2024
Lithuania
87.0%
in 2024
Dominican Republic rank
78th
Lithuania rank
78th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Dominican Republic
- Lithuania
How they compare
Dominican Republic currently reports 87.0% against 87.0% in Lithuania, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2016 it was Lithuania ahead.
Dominican Republic ranks 78th and Lithuania ranks 78th of 146 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Dominican Republic | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.8% | 82.2% | 25.5% | Lithuania |
| 2020s | 78.2% | 83.0% | 4.8% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Dominican Republic or Lithuania?
- Dominican Republic, at 87.0% against 87.0% in Lithuania as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Dominican Republic and Lithuania?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Lithuania?
- 9 years are reported by both, from 2016 to 2024.
- How do Dominican Republic and Lithuania rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Dominican Republic ranks 78th and Lithuania ranks 78th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.